J. Machiels Et Al. , "Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412," FUTURE ONCOLOGY , vol.16, no.18, pp.1235-1244, 2020
Machiels, J. Et Al. 2020. Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412. FUTURE ONCOLOGY , vol.16, no.18 , 1235-1244.
Machiels, J., Tao, Y., Burtness, B., Tahara, M., Licitra, L., Rischin, D., ... Waldron, J.(2020). Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412. FUTURE ONCOLOGY , vol.16, no.18, 1235-1244.
Machiels, Jean-Pascal Et Al. "Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412," FUTURE ONCOLOGY , vol.16, no.18, 1235-1244, 2020
Machiels, Jean-Pascal Et Al. "Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412." FUTURE ONCOLOGY , vol.16, no.18, pp.1235-1244, 2020
Machiels, J. Et Al. (2020) . "Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412." FUTURE ONCOLOGY , vol.16, no.18, pp.1235-1244.
@article{article, author={Jean-Pascal Machiels Et Al. }, title={Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412}, journal={FUTURE ONCOLOGY}, year=2020, pages={1235-1244} }